ERVW-1 and COVID-19: Third, the inactivated COVID-19 vaccine contained multiple viral proteins, antibodies, and cellular immune responses against non-spike proteins, including nucleocapsid, membrane, and envelope proteins, which may also contribute to vaccine protection efficiency and should be evaluated in further studies.